Literature DB >> 19213957

Substrate-enzyme competition attenuates upregulated anaplerotic flux through malic enzyme in hypertrophied rat heart and restores triacylglyceride content: attenuating upregulated anaplerosis in hypertrophy.

Kayla M Pound1, Natalia Sorokina, Kalpana Ballal, Deborah A Berkich, Mathew Fasano, Kathryn F Lanoue, Heinrich Taegtmeyer, J Michael O'Donnell, E Douglas Lewandowski.   

Abstract

Recent work identifies the recruitment of alternate routes for carbohydrate oxidation, other than pyruvate dehydrogenase (PDH), in hypertrophied heart. Increased carboxylation of pyruvate via cytosolic malic enzyme (ME), producing malate, enables "anaplerotic" influx of carbon into the citric acid cycle. In addition to inefficient NADH production from pyruvate fueling this anaplerosis, ME also consumes NADPH necessary for lipogenesis. Thus, we tested the balance between PDH and ME fluxes in hypertrophied hearts and examined whether low triacylglyceride (TAG) was linked to ME-catalyzed anaplerosis. Sham-operated (SHAM) and aortic banded rat hearts (HYP) were perfused with buffer containing either 13C-palmitate plus glucose or (13)C glucose plus palmitate for 30 minutes. Hearts remained untreated or received dichloroacetate (DCA) to activate PDH and increase substrate competition with ME. HYP showed a 13% to 26% reduction in rate pressure product (RPP) and impaired dP/dt versus SHAM (P<0.05). DCA did not affect RPP but normalized dP/dt in HYP. HYP had elevated ME expression with a 90% elevation in anaplerosis over SHAM. Increasing competition from PDH reduced anaplerosis in HYP+DCA by 18%. Correspondingly, malate was 2.2-fold greater in HYP than SHAM but was lowered with PDH activation: HYP=1419+/-220 nmol/g dry weight; HYP+DCA=343+/-56 nmol/g dry weight. TAG content in HYP (9.7+/-0.7 micromol/g dry weight) was lower than SHAM (13.5+/-1.0 micromol/g dry weight). Interestingly, reduced anaplerosis in HYP+DCA corresponded with normalized TAG (14.9+/-0.6 micromol/g dry weight) and improved contractility. Thus, we have determined partial reversibility of increased anaplerosis in HYP. The findings suggest anaplerosis through NADPH-dependent, cytosolic ME limits TAG formation in hypertrophied hearts.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19213957      PMCID: PMC2908318          DOI: 10.1161/CIRCRESAHA.108.189951

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  28 in total

Review 1.  Anaplerosis of the citric acid cycle: role in energy metabolism of heart and skeletal muscle.

Authors:  M J Gibala; M E Young; H Taegtmeyer
Journal:  Acta Physiol Scand       Date:  2000-04

2.  Dichloroacetate improves postischemic function of hypertrophied rat hearts.

Authors:  R B Wambolt; G D Lopaschuk; R W Brownsey; M F Allard
Journal:  J Am Coll Cardiol       Date:  2000-10       Impact factor: 24.094

3.  Coupling of mitochondrial fatty acid uptake to oxidative flux in the intact heart.

Authors:  J Michael O'Donnell; Nathaniel M Alpert; Lawrence T White; E Douglas Lewandowski
Journal:  Biophys J       Date:  2002-01       Impact factor: 4.033

Review 4.  Energy metabolism in the hypertrophied heart.

Authors:  Nandakumar Sambandam; Gary D Lopaschuk; Roger W Brownsey; Michael F Allard
Journal:  Heart Fail Rev       Date:  2002-04       Impact factor: 4.214

Review 5.  Gene regulatory mechanisms governing energy metabolism during cardiac hypertrophic growth.

Authors:  John J Lehman; Daniel P Kelly
Journal:  Heart Fail Rev       Date:  2002-04       Impact factor: 4.214

6.  Pyruvate dehydrogenase and the regulation of glucose oxidation in hypertrophied rat hearts.

Authors:  Carmen P Lydell; Andy Chan; Richard B Wambolt; Nandakumar Sambandam; Hannah Parsons; Gregory P Bondy; Brian Rodrigues; Kirill M Popov; Robert A Harris; Roger W Brownsey; Michael F Allard
Journal:  Cardiovasc Res       Date:  2002-03       Impact factor: 10.787

7.  Accelerated rates of glycolysis in the hypertrophied heart: are they a methodological artifact?

Authors:  Hon Sing Leong; Mark Grist; Hannah Parsons; Richard B Wambolt; Gary D Lopaschuk; Roger Brownsey; Michael F Allard
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-05       Impact factor: 4.310

8.  [5-3H]glucose overestimates glycolytic flux in isolated working rat heart: role of the pentose phosphate pathway.

Authors:  G W Goodwin; D M Cohen; H Taegtmeyer
Journal:  Am J Physiol Endocrinol Metab       Date:  2001-03       Impact factor: 4.310

Review 9.  Glycolysis and pyruvate oxidation in cardiac hypertrophy--why so unbalanced?

Authors:  H S Leong; R W Brownsey; J E Kulpa; M F Allard
Journal:  Comp Biochem Physiol A Mol Integr Physiol       Date:  2003-08       Impact factor: 2.320

10.  Glucose-6-phosphate dehydrogenase modulates cytosolic redox status and contractile phenotype in adult cardiomyocytes.

Authors:  Mohit Jain; Daniel A Brenner; Lei Cui; Chee Chew Lim; Bo Wang; David R Pimentel; Stanley Koh; Douglas B Sawyer; Jane A Leopold; Diane E Handy; Joseph Loscalzo; Carl S Apstein; Ronglih Liao
Journal:  Circ Res       Date:  2003-06-26       Impact factor: 17.367

View more
  74 in total

Review 1.  Imaging myocardial metabolic remodeling.

Authors:  Robert J Gropler; Rob S B Beanlands; Vasken Dilsizian; E Douglas Lewandowski; Flordeliza S Villanueva; Maria Cecilia Ziadi
Journal:  J Nucl Med       Date:  2010-05-01       Impact factor: 10.057

Review 2.  Emerging characterization of the role of SIRT3-mediated mitochondrial protein deacetylation in the heart.

Authors:  Michael N Sack
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-10-07       Impact factor: 4.733

Review 3.  Metabolic stress in the myocardium: adaptations of gene expression.

Authors:  Peter A Crawford; Jean E Schaffer
Journal:  J Mol Cell Cardiol       Date:  2012-06-21       Impact factor: 5.000

4.  Innate short-circuiting of mitochondrial metabolism in cardiac hypertrophy: identification of novel consequences of enhanced anaplerosis.

Authors:  Michael N Sack
Journal:  Circ Res       Date:  2009-03-27       Impact factor: 17.367

Review 5.  Cardiac metabolism in heart failure: implications beyond ATP production.

Authors:  Torsten Doenst; Tien Dung Nguyen; E Dale Abel
Journal:  Circ Res       Date:  2013-08-30       Impact factor: 17.367

6.  Metabolomic analysis of pressure-overloaded and infarcted mouse hearts.

Authors:  Brian E Sansbury; Angelica M DeMartino; Zhengzhi Xie; Alan C Brooks; Robert E Brainard; Lewis J Watson; Andrew P DeFilippis; Timothy D Cummins; Matthew A Harbeson; Kenneth R Brittian; Sumanth D Prabhu; Aruni Bhatnagar; Steven P Jones; Bradford G Hill
Journal:  Circ Heart Fail       Date:  2014-04-24       Impact factor: 8.790

7.  Metabolomic profiling of the heart during acute ischemic preconditioning reveals a role for SIRT1 in rapid cardioprotective metabolic adaptation.

Authors:  Sergiy M Nadtochiy; William Urciuoli; Jimmy Zhang; Xenia Schafer; Joshua Munger; Paul S Brookes
Journal:  J Mol Cell Cardiol       Date:  2015-09-24       Impact factor: 5.000

Review 8.  Matrix revisited: mechanisms linking energy substrate metabolism to the function of the heart.

Authors:  Andrew N Carley; Heinrich Taegtmeyer; E Douglas Lewandowski
Journal:  Circ Res       Date:  2014-02-14       Impact factor: 17.367

9.  Multiphasic triacylglycerol dynamics in the intact heart during acute in vivo overexpression of CD36.

Authors:  Andrew N Carley; Jian Bi; Xuerong Wang; Natasha H Banke; Jason R B Dyck; J Michael O'Donnell; E Douglas Lewandowski
Journal:  J Lipid Res       Date:  2012-10-25       Impact factor: 5.922

10.  Dipropionylcysteine ethyl ester compensates for loss of citric acid cycle intermediates during post ischemia reperfusion in the pig heart.

Authors:  Takhar Kasumov; Naveen Sharma; Hazel Huang; Rajan S Kombu; Andrea Cendrowski; William C Stanley; Henri Brunengraber
Journal:  Cardiovasc Drugs Ther       Date:  2009-12       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.